Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
175M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
-1.68M
-
Total reported value, excl. options
-
$407M
-
Value change
-
-$67.5M
-
Put/Call ratio
-
0.25
-
Number of buys
-
65
-
Number of sells
-
-58
-
Price
-
$10.57
Significant Holders of Immunovant, Inc. - COMMON STOCK (IMVT) as of Q2 2021
162 filings reported holding IMVT - Immunovant, Inc. - COMMON STOCK as of Q2 2021.
Immunovant, Inc. - COMMON STOCK (IMVT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
of 175M outstanding shares and own 21.97% of the company stock.
Largest 10 shareholders include STATE STREET CORP (4.39M shares), VANGUARD GROUP INC (4M shares), Woodline Partners LP (3.75M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.37M shares), BlackRock Inc. (3.1M shares), Alpine Global Management, LLC (2M shares), MORGAN STANLEY (1.54M shares), TWO SIGMA INVESTMENTS, LP (1.28M shares), BVF INC/IL (1.27M shares), and BOXER CAPITAL, LLC (1M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.